Purpose
|
Brivanib alaninate (BMS-582664) is the prodrug of BMS-540215, an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM.
|
Characteristics
|
Target: VEGFR inhibitor Receptor: VEGFR2,Flk1,FGFR1,VEGFR1
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
97?% +
|
Formula
|
C22H24FN5O4
|
Solubility
|
200 mM in DMSO and ethanol
|